Sialylated Human Milk Oligosaccharides (HMO) Supply, Demand and Key Producers, 2026-2032: size and forecast, segments, key players

Drawn from Global Sialylated Human Milk Oligosaccharides (HMO) Supply, Demand and Key Producers, 2026-2032, 98 pages. Every figure, segment and company below is stated in that report.

Market size and forecast

The global Sialylated Human Milk Oligosaccharides (HMO) market size is expected to reach $ 441 million by 2032, rising at a market growth of 16.1% CAGR during the forecast period (2026-2032).

How the market is segmented

By Type

• 3'-Sialyllactose (3'-SL)
• 6'-Sialyllactose (6'-SL)

By Process

• Microbial Fermentation
• Enzymatic Synthesis

By Grade

• Food Grade
• Research Grade

By Application

• Infant Formula
• Food
• Others

Companies the report covers

• Novonesis,
• Inbiose,
• DSM (Glycom A/S),
• Kyowa Hakko Bio,
• GeneChem Inc.,
• Elicityl,
• Zhuhai Langjian Biotechnology,
• Shanghai HuicH Biotech

Regions covered

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

What the report contains

1. 1 Supply Summary
2. 2 Demand Summary
3. 3 World Manufacturers Competitive Analysis
4. 4 United States VS China VS Rest OF The World
5. 5 Market Analysis BY Type
6. 6 Market Analysis BY Process
7. 7 Market Analysis BY Grade
8. 8 Market Analysis BY Application
9. 9 Company Profiles
10. 10 Industry Chain Analysis
11. 11 Research Findings And Conclusion
12. 12 Appendix
13. List OF Tables
14. List OF Figures

Full report, table of contents and licence options →